Healthcare provider profile · identity verified

Connie Spears, FNP

Nurse Practitioner · LEWISTON, ID · NPI 1881228781

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	317	112
Levothyroxine Sodium	Levothyroxine Sodium	315	64
Potassium Chloride	Potassium Chloride	273	77
Atorvastatin Calcium	Atorvastatin Calcium	235	65
Furosemide	Furosemide	210	67
Gabapentin	Gabapentin	192	59
Eliquis	Apixaban	176	37
Losartan Potassium	Losartan Potassium	123	47
Amlodipine Besylate	Amlodipine Besylate	122	41
Oxycodone Hcl	Oxycodone Hcl	115	45
Spironolactone	Spironolactone	112	34
Fentanyl	Fentanyl	108	28
Omeprazole	Omeprazole	103	36
Trazodone Hcl	Trazodone Hcl	103	32
Lisinopril	Lisinopril	99	27
Pregabalin	Pregabalin	96	21
Tramadol Hcl	Tramadol Hcl	95	30
Clopidogrel	Clopidogrel Bisulfate	94	29
Pantoprazole Sodium	Pantoprazole Sodium	90	34
Metoprolol Succinate	Metoprolol Succinate	85	38
Lorazepam	Lorazepam	78	24
Metoprolol Tartrate	Metoprolol Tartrate	76	27
Mirtazapine	Mirtazapine	72	20
Duloxetine Hcl	Duloxetine Hcl	71	29
Tamsulosin Hcl	Tamsulosin Hcl	70	23
Buspirone Hcl	Buspirone Hcl	69	18
Escitalopram Oxalate	Escitalopram Oxalate	67	15
Torsemide	Torsemide	67	21
Donepezil Hcl	Donepezil Hcl	57	14
Hydrochlorothiazide	Hydrochlorothiazide	57	17
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	57	17
Methocarbamol	Methocarbamol	54	33
Sertraline Hcl	Sertraline Hcl	54	18
Metformin Hcl	Metformin Hcl	53	24
Allopurinol	Allopurinol	51	23
Prednisone	Prednisone	51	35
Morphine Sulfate	Morphine Sulfate	46	17
Ondansetron Hcl	Ondansetron Hcl	46	29
Hydroxyzine Hcl	Hydroxyzine Hcl	45	15
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	45	23
Glipizide	Glipizide	43	11
Metoclopramide Hcl	Metoclopramide Hcl	43	suppressed
Myrbetriq	Mirabegron	43	suppressed
Baclofen	Baclofen	42	13
Ropinirole Hcl	Ropinirole Hcl	42	15
Citalopram Hbr	Citalopram Hydrobromide	41	15
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	37	suppressed
Memantine Hcl	Memantine Hcl	35	suppressed
Ozempic	Semaglutide	33	11
Carbidopa-Levodopa	Carbidopa/Levodopa	32	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	32	18
Oxybutynin Chloride	Oxybutynin Chloride	31	suppressed
Cephalexin	Cephalexin	30	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	30	29
Quetiapine Fumarate	Quetiapine Fumarate	30	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	29	suppressed
Nystatin	Nystatin	29	15
Latanoprost	Latanoprost	27	suppressed
Levetiracetam	Levetiracetam	27	suppressed
Meloxicam	Meloxicam	27	suppressed
Fluconazole	Fluconazole	26	13
Ondansetron Odt	Ondansetron	25	22
Albuterol Sulfate Hfa	Albuterol Sulfate	24	22
Simvastatin	Simvastatin	24	suppressed
Naloxone Hcl	Naloxone Hcl	23	23
Humalog Kwikpen U-100	Insulin Lispro	22	suppressed
Carvedilol	Carvedilol	21	12
Divalproex Sodium	Divalproex Sodium	21	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	21	suppressed
Hydralazine Hcl	Hydralazine Hcl	21	11
Lubiprostone	Lubiprostone	21	suppressed
Aripiprazole	Aripiprazole	20	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	20	19
Famotidine	Famotidine	20	12
Meclizine Hcl	Meclizine Hcl	20	suppressed
Warfarin Sodium	Warfarin Sodium	19	suppressed
Buprenorphine	Buprenorphine	18	suppressed
Diazepam	Diazepam	18	suppressed
Diltiazem Hcl	Diltiazem Hcl	18	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	18	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	18	suppressed
Propranolol Hcl	Propranolol Hcl	18	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	18	17
Olanzapine	Olanzapine	17	suppressed
Ranolazine Er	Ranolazine	17	suppressed
Trulicity	Dulaglutide	17	suppressed
Finasteride	Finasteride	16	suppressed
Nitroglycerin	Nitroglycerin	16	suppressed
Risperidone	Risperidone	16	suppressed
Azithromycin	Azithromycin	15	15
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	15	suppressed
Methenamine Hippurate	Methenamine Hippurate	15	suppressed
Morphine Sulfate Er	Morphine Sulfate	15	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	15	suppressed
Alendronate Sodium	Alendronate Sodium	14	suppressed
Ibuprofen	Ibuprofen	14	suppressed
Montelukast Sodium	Montelukast Sodium	14	suppressed
Ventolin Hfa	Albuterol Sulfate	14	11
Glimepiride	Glimepiride	13	suppressed
Hydrocortisone	Hydrocortisone	13	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	13	suppressed
Oxycontin	Oxycodone Hcl	13	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	13	suppressed
Amiodarone Hcl	Amiodarone Hcl	12	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	12	11
Breo Ellipta	Fluticasone/Vilanterol	12	suppressed
Bupropion Hcl Sr	Bupropion Hcl	12	suppressed
Cholestyramine Light	Cholestyramine	12	suppressed
Ketoconazole	Ketoconazole	12	suppressed
Midodrine Hcl	Midodrine Hcl	12	suppressed
Niacin Er	Niacin	12	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	12	suppressed
Spiriva Respimat	Tiotropium Bromide	12	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	12	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	11	suppressed
Chlorthalidone	Chlorthalidone	11	suppressed
Clonazepam	Clonazepam	11	suppressed
Febuxostat	Febuxostat	11	suppressed
Rivastigmine	Rivastigmine Tartrate	11	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error